A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Sponsored by Merck Sharp & Dohme LLC
About this study
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Where this study is enrolling (41)
- Call 480-256-6444
Banner MD Anderson Cancer Center-Oncology ( Site 0004)
Gilbert, Arizona
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 480-821-2838
Ironwood Cancer & Research Centers ( Site 0066)
Chandler, Arizona
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 714-446-5900
Providence Medical Foundation-Oncology ( Site 0020)
Fullerton, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 562-353-1200
Cancer and Blood Specialty Clinic ( Site 0001)
Los Alamitos, California
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 303-724-6077
University of Colorado Anschutz Medical Campus ( Site 0061)
Aurora, Colorado
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Show all 41 locations
- Call 720-848-1030
UCHealth Cherry Creek Medical Center ( Site 0094)
Denver, Colorado
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 203-276-1000
Stamford Hospital ( Site 0049)
Stamford, Connecticut
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 203-688-4242
Yale Cancer Center ( Site 0060)
New Haven, Connecticut
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 407-834-5151
AdventHealth Altamonte Springs ( Site 0021)
Altamonte Springs, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 321-843-8370
Orlando Health Cancer Institute ( Site 0011)
Orlando, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 229-584-5400
Archbold Memorial Hospital-Lewis Hall Singletary Oncology Center ( Site 0032)
Thomasville, Georgia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Rush University Medical Center ( Site 0079)
Chicago, Illinois
- I'm interested
University of Chicago Medical Center ( Site 0067)
Chicago, Illinois
- Call 859-301-4245
Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053)
Edgewood, Kentucky
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 888-501-4763
Mary Bird Perkins Cancer Center-Breast & GYN Pavilion ( Site 0042)
Baton Rouge, Louisiana
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 410-328-6373
Greenebaum Comprehensive Cancer Center ( Site 0036)
Baltimore, Maryland
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 301-754-7000
Holy Cross Hospital ( Site 0073)
Silver Spring, Maryland
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 857-215-3246
Dana-Farber Cancer Institute-Breast Oncology Center ( Site 0037)
Boston, Massachusetts
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 313-916-2576
Henry Ford Health ( Site 0002)
Detroit, Michigan
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 816-932-2677
Saint Luke's Cancer Institute ( Site 0027)
Kansas City, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 314-454-8313
Washington University School of Medicine ( Site 0076)
St Louis, Missouri
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 212-731-6000
Laura and Isaac Perlmutter Cancer Center-Hematology and Oncology ( Site 0068)
New York, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 212-731-6000
NYU Langone Hospital - Long Island ( Site 0090)
Mineola, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 212-731-6000
NYU Langone Health - Brooklyn ( Site 0089)
Brooklyn, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 631-444-4392
Stony Brook University-Cancer Center ( Site 0034)
Stony Brook, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 845-362-1750
Hematology Oncology Associates of Rockland ( Site 0054)
Nyack, New York
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 980-442-2000
Levine Cancer Institute ( Site 0014)
Charlotte, North Carolina
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 503-215-2619
Providence St. Vincent Medical Center ( Site 0081)
Portland, Oregon
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 503-215-2619
Providence Portland Medical Center ( Site 0044)
Portland, Oregon
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 215-906-5938
Thomas Jefferson University - Clinical Research Institute ( Site 0056)
Philadelphia, Pennsylvania
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 214-590-8000
Parkland Health and Hospital System ( Site 0069)
Dallas, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 903-595-7093
The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0057)
Tyler, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 817-759-7000
The Center for Cancer and Blood Disorders ( Site 0041)
Fort Worth, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 214-265-2080
Texas Oncology-Dallas Presbyterian Hospital ( Site 8000)
Dallas, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 214-648-3111
UT Southwestern Medical Center ( Site 0050)
Dallas, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 212-241-0493
Texas Oncology - San Antonio ( Site 8002)
San Antonio, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 804-594-7300
Bon Secours St. Francis Medical Center-Oncology Research ( Site 0015)
Midlothian, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 571-472-4724
Inova Schar Cancer Institute ( Site 0025)
Fairfax, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 877-462-7739
VCU Health Adult Outpatient Pavillion ( Site 0070)
Richmond, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 844-482-4812
Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 8001)
Roanoke, Virginia
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- Call 800-622-8922
University Hospital and UW Health Clinics-Carbone Cancer Center ( Site 0040)
Madison, Wisconsin
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓Has unresectable locally advanced or metastatic centrally-confirmed hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer
- ✓Has radiographic disease progression on one or more lines of endocrine therapy for unresectable locally advanced/metastatic HR+/HER2- breast cancer, with one in combination with a CDK4/6 inhibitor
- ✓Is a chemotherapy candidate
- ✓Has an eastern cooperative oncology group (ECOG) performance status of 0 to 1 assessed within 7 days before randomization
- ✓Has adequate organ function
- ✓Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy
- ✓Participants who are Hepatitis B surface antigen (HBsAg) positive are eligible if they have received HBV antiviral therapy for at least 4 weeks, and have undetectable HBV viral load
- ✓Participants with a history of Hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable
Exclusion criteria
- ✕Has breast cancer amenable to treatment with curative intent
- ✕Has experienced an early recurrence (\<6 months after completing adjuvant/neoadjuvant chemotherapy) and therefore is eligible to receive second-line (2L) treatment
- ✕Has symptomatic advanced/metastatic visceral spread at risk of rapidly evolving into life-threatening complications
- ✕Has received prior chemotherapy for unresectable locally advanced or metastatic breast cancer
- ✕Active autoimmune disease that has required systemic treatment in the past 2 years
- ✕History of (noninfectious) pneumonitis/interstitial lung disease that requires steroids, or has current pneumonitis/interstitial lung disease
- ✕Has an active infection requiring systemic therapy
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.